No Data
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Avails Medical Welcomes Dan Douglas as Vice President of Finance
Morgan Stanley Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $42
Scotiabank Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $47
No Data
No Data